171 related articles for article (PubMed ID: 18469798)
1. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma.
Aviel-Ronen S; Lau SK; Pintilie M; Lau D; Liu N; Tsao MS; Jothy S
Mod Pathol; 2008 Jul; 21(7):817-25. PubMed ID: 18469798
[TBL] [Abstract][Full Text] [Related]
2. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis].
Li H; Deng Q; Huang L; Tang H; Cheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance.
Yu X; Li Y; Chen SW; Shi Y; Xu F
Genet Mol Res; 2015 Aug; 14(3):10185-92. PubMed ID: 26345955
[TBL] [Abstract][Full Text] [Related]
4. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
5. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
6. Expression of GPC3 protein and its significance in lung squamous cell carcinoma.
Lin Q; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
Med Oncol; 2012 Jun; 29(2):663-9. PubMed ID: 21556932
[TBL] [Abstract][Full Text] [Related]
7. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
[TBL] [Abstract][Full Text] [Related]
8. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
[TBL] [Abstract][Full Text] [Related]
10. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
[TBL] [Abstract][Full Text] [Related]
11. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.
Kim H; Xu GL; Borczuk AC; Busch S; Filmus J; Capurro M; Brody JS; Lange J; D'Armiento JM; Rothman PB; Powell CA
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):694-701. PubMed ID: 12816733
[TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers.
Nelson MA; Wymer J; Clements N
Cancer Lett; 1996 May; 103(1):115-21. PubMed ID: 8616804
[TBL] [Abstract][Full Text] [Related]
13. hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment.
Vageli DP; Zaravinos A; Daniil Z; Dahabreh J; Doukas SG; Spandidos DA; Gourgoulianis KI; Koukoulis GK
Int J Biol Markers; 2013 Jan; 27(4):e400-4. PubMed ID: 22865300
[TBL] [Abstract][Full Text] [Related]
14. [High expression of DNMT1 was correlated with beta-catenin accumulation and malignant phynotype of lung squamous cell carcinoma and adenocarcinoma].
Xu H; Wang Z; Liu D; Li Q; Dai S; Wang E
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):856-60. PubMed ID: 20840813
[TBL] [Abstract][Full Text] [Related]
15. Biliary glycoprotein mRNA expression is increased in primary lung cancer, especially in squamous cell carcinoma.
Ohwada A; Takahashi H; Nagaoka I; Kira S
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):214-20. PubMed ID: 8049082
[TBL] [Abstract][Full Text] [Related]
16. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.
Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS
BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340
[TBL] [Abstract][Full Text] [Related]
17. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
[TBL] [Abstract][Full Text] [Related]
19. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
Deng B; Sun Z; Jason W; Yang P
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
[TBL] [Abstract][Full Text] [Related]
20. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.
Pelosi G; Scarpa A; Manzotti M; Veronesi G; Spaggiari L; Fraggetta F; Nappi O; Benini E; Pasini F; Antonello D; Iannucci A; Maisonneuve P; Viale G
Mod Pathol; 2004 May; 17(5):538-46. PubMed ID: 14990969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]